Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point?

Fuente: Wiley Open Access
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Andrea Duminuco, Antonella Nardo, Giuseppe A. Palumbo
Format: Artículo Open Access
Publié: Wiley 2024
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1867020512423575552
author Andrea Duminuco
Antonella Nardo
Giuseppe A. Palumbo
author_facet Andrea Duminuco
Antonella Nardo
Giuseppe A. Palumbo
Andrea Duminuco
Antonella Nardo
Giuseppe A. Palumbo
collection Wiley Open Access
contents Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point? Andrea Duminuco Antonella Nardo Giuseppe A. Palumbo Hematological Oncology 10.1002/hon.3259 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/hon.3259
format Artículo Open Access
id wiley_oa_10_1002_hon_3259
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point?
Andrea Duminuco
Antonella Nardo
Giuseppe A. Palumbo
Hematological Oncology
Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point? Andrea Duminuco Antonella Nardo Giuseppe A. Palumbo Hematological Oncology 10.1002/hon.3259 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point?
topic Hematological Oncology
url https://onlinelibrary.wiley.com/doi/10.1002/hon.3259